R Squared Ltd Invests $617,000 in Danaher Corporation $DHR

R Squared Ltd acquired a new stake in Danaher Corporation (NYSE:DHR) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,252 shares of the conglomerate’s stock, valued at approximately $617,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter valued at approximately $26,000. WFA of San Diego LLC bought a new position in Danaher during the 2nd quarter worth approximately $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher during the 4th quarter worth approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its holdings in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 0.0%

NYSE DHR traded down $0.06 on Tuesday, reaching $193.56. The company had a trading volume of 745,489 shares, compared to its average volume of 4,333,654. The firm has a market capitalization of $137.00 billion, a price-to-earnings ratio of 37.42, a price-to-earnings-growth ratio of 2.52 and a beta of 0.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company’s fifty day moving average is $179.01 and its 200-day moving average is $200.34.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $1.88 EPS. On average, research analysts forecast that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Ratings Changes

DHR has been the subject of several recent analyst reports. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. The Goldman Sachs Group dropped their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Finally, DZ Bank started coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $233.52.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.